Related Experiment Video
Updated: Mar 22, 2026
13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
10.0K
Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma.
Chiea Chuen Khor1,2,3, Tan Do4, Hongyan Jia5
1Genome Institute of Singapore, A-STAR, Singapore.
Nature Genetics
|April 12, 2016
Summary
Primary angle closure glaucoma (PACG) is a leading cause of blindness. This genome-wide association study identified five new genetic loci, advancing our understanding of PACG
Area of Science:
- Genetics
- Ophthalmology
- Genomics
Background:
- Primary angle closure glaucoma (PACG) is a significant global cause of irreversible blindness.
- Understanding the genetic underpinnings of PACG is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To identify novel genetic loci associated with primary angle closure glaucoma (PACG).
- To expand the understanding of the genetic architecture contributing to PACG.
Main Methods:
- A large-scale genome-wide association study (GWAS) was conducted.
- Meta-analysis combined data from 10,503 PACG cases and 29,567 controls across 24 countries.
- Replication studies were performed to validate findings.
Main Results:
- Five novel genetic loci (EPDR1, CHAT, GLIS3, FERMT2, DPM2-FAM102A) showed significant association with PACG.
- Previously identified loci (PLEKHA7, COL11A1, PCMTD1-ST18) were confirmed.
- The identified loci provide new insights into the biological pathways involved in PACG.
Conclusions:
- This study significantly expands the number of known genetic risk factors for PACG.
- The findings contribute to a deeper comprehension of PACG pathogenesis.
- These genetic discoveries pave the way for future research into targeted therapies.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
16.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.6K
01:28Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
01:25Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:05Single Nucleotide Polymorphisms-SNPs
19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K